20639 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs Umbilical cord; Umbilical cord blood; Umbilical stem cells
METHOD FOR PREVENTING INFECTION OF A HEALTHY PERSON OR A HEALTHY ANIMAL WITH A VIRUS THAT USES ACE2 AS A RECEPTOR, BINDING INHIBITOR AND MEDICAL DEVICE
#2COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF
#3CLINICAL DERIVATIONS OF AN ALLOGENIC CELL AND THERAPEUTIC USES
#4METHOD FOR OBTAINING AN UMBILICAL CORD EXTRACT
#5ACELLULAR ALLOGENIC EXOSOME PREPARATIONS AND METHODS OF USE
#6COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME
#7UMBILICAL LINING-DERIVED STEM CELLS FOR TREATING IDIOPATHIC INFLAMMATORY MYOPATHY
#8HYDROGEL COMPOSITIONS CONTAINING CELLULAR PRODUCTS
#9FIBROUS BIRTH TISSUE COMPOSITION AND METHOD OF USE
#10COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE
#11METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#12PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OVARIAN FAILURE COMPRISING UMBILICAL CORD-DERIVED ADHERENT STEM CELLS
#13MIXTURES OF PLACENTAL PARTICLES, GRAFTS INCLUDING THEM, AND METHODS FOR MAKING AND USING THEM
#14METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#15HUMAN UMBILICAL CORD BLOOD FOR USE IN ALLEVIATING FATIGUE
#16PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION
#17PREVENTION OF AUTOIMMUNE DIABETES
#18METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#19COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)
#20ENGINEERED CELLS AND USES THEREOF
#21COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION
#22SYSTEM AND METHOD FOR THERAPEUTIC COMPOSITIONS FROM A PLURALITY OF DIFFERENT BIRTH TISSUES AND EXOSOMES
#23METHOD OF PRODUCTION AND USE OF PREPARATION COMPRISING CODON-OPTIMIZED HUMAN COAGULATION FACTOR IX (hFIXco)-TRANSDUCED HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS (tr-HUCMSCs)
#24HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE
#25NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#26HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#27COMPOSITIONS
#28Topical Sports Cream Composition
#29METHODS OF TREATMENT UTILIZING CANINE-SPECIFIC THERAPEUTIC COMPOSITIONS
#30MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#31HUMAN UMBILICAL COMPOSITIONS AND METHODS FOR DERMAL APPLICATION
#32MITOCHONDRIAL AUGMENTATION THERAPY FOR MYELODYSPLASTIC SYNDROME
#33USE OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED SMALL EXTRACELLULAR VESICLE (hucMSC-sEV) IN PREPARATION OF DRUG FOR TREATING TYPE 2 DIABETES MELLITUS (T2DM)
#34SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION
#35COMPOSITION COMPRISING CORD BLOOD PLATELET RICH PLASMA (CB-PRP) IN PRE-FILLED SYRINGE AND USES THEREOF
#36BIOLOGICAL MATERIAL IMPREGNATED WITH A SOLUTION COMPRISING EXOSOMES
#37PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE
#38PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES
#39UMBILICAL CORD BLOOD MONONUCLEAR CELLS AND RED CELL FRACTION IMPROVE NEUROGENESIS AND BEHAVIORAL RECOVERY AFTER HYPOXIA-ISCHEMIC BRAIN DAMAGE
#40Methods and Systems for Generation, Use, and Delivery of Activated Stem Cells
#41TRIAZOLE CONTAINING POLYMERS AND METHODS OF USE THEREOF
#42PHARMACEUTICAL USE OF CORD BLOOD IMMUNOSUPPRESSIVE CELL
#43COMPOSITIONS AND METHODS RELATING TO POOLED FETAL SUPPORT TISSUE
#44MESENCHYMAL STEM CELLS OBTAINED FROM WHARTON'S JELLY FOR THE TREATMENT OF SEPSIS
#45COMPOSITION AND USE THEREOF
#46HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE
#47UMBILICAL CORD MESENCHYMAL CELL EXTRACELLULAR VESICLES FOR THE TREATMENT OF OSTEOARTICULAR AND AUTOIMMUNE DISEASES
#48PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE
#49Methods for protecting a parathyroid
#50Systems and Methods For Delivering Exosomes Through the Blood-Brain Barrier
#51TWO-PART CLOTTING COMPOSITION AND METHODS OF MAKING AND USING THEREOF
#52USE OF UMBILICAL CORD BLOOD DERIVED EXOSOMES FOR TISSUE REPAIR
#53COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING, AS ACTIVE INGREDIENT STEM CELLS OVEREXPRESSING SOD3
#54METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS
#55PREVENTION OF SPACE TRAVEL ASSOCIATED BONE DENSITY LOSS BY REGENERATIVE CELL POPULATIONS
#56METHOD FOR PREPARING HIGH-CONCENTRATION STEM CELL EXOSOMES WITH ENHANCED ANTI-INFLAMMATORY AND REGENERATIVE FUNCTIONS USING LIPOPOLYSACCHARIDE AND LIPOTEICHOIC ACID
#57METHODS OF USING UMBILICAL CORD PRODUCTS FOR TREATMENT OF OCULAR SURFACE DISORDERS
#58PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING TENDON OR LIGAMENT DISEASES, COMPRISING UMBILICAL CORD-DERIVED STEM CELLS AS ACTIVE INGREDIENT
#59Vaginal care compositions and methods of improving vaginal health
#60FETAL SUPPORT TISSUE PRODUCTS AND METHODS OF USE
#61SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION
#62SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION
#63METHODS OF TREATING SYSTEMIC GRAFT- VERSUS-HOST DISEASE WITH EXTRACELLULAR VESICLES
#64CELL PREPARATION FOR USE IN SUPPRESSING MUSCLE MASS LOSS
#65COMPOSITIONS AND METHODS OF TREATING DRY EYE SYNDROME AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES
#66METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS
#67UMBILICAL CORD PRODUCTS
#68UMBILICAL CORD-DERIVED ADHERENT STEM CELLS, PREPARATION METHOD THEREFOR, AND USE THEREOF
#69PREVENTION OF RADIATION EXPOSURE ASSOCIATED PATHOLOGY BY TREATMENT WITH UMBILICAL CORD DERIVED REGENERATIVE CELLS
#70CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#71Two-part clotting composition and methods of making and using thereof
#72CRANIAL NEUROPATHY THERAPEUTIC AGENT CONTAINING CULTURE SUPERNATANT FOR UMBILICAL CORD BLOOD MONOCYTIC CELLS
#73UMBILICAL CORD DERIVED REGENERATIVE AND IMMUNE MODULATORY STEM CELL POPULATIONS
#74CORD BLOOD PLASMA-DERIVED EXOSOME OR MIMETIC THEREOF AND PHARMACEUTICAL USE THEREOF
#75METHODS AND MATERIALS FOR TREATING NON-MALIGNANT DISORDERS OR DISEASES WITH CORD BLOOD
#76METHOD FOR PREVENTING INFECTION OF A HEALTHY PERSON OR A HEALTHY ANIMAL WITH A VIRUS THAT USES ACE2 AS A RECEPTOR, BINDING INHIBITOR AND MEDICAL DEVICE
#77HIGH-POTENTIAL PLURIPOTENT STEM CELLS
#78FIBROUS BIRTH TISSUE COMPOSITION AND METHOD OF USE
#79METHOD FOR ADMINISTERING UMBILICAL CORD BLOOD OR PERIPHERAL BLOOD
#80METHODS OF PROMOTING VASCULOGENESIS
#81METHOD FOR PREPARING CULTURE MEDIUM CONTAINING HIGH LEVELS OF HIGH-POTENCY EXOSOMES SECRETED BY CORD BLOOD STEM CELLS, AND USE THEREOF
#82COMPOSITION COMPRISING CORD BLOOD PLATELET RICH PLASMA (CB-PRP) AND USES THEROF
#83IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING CANCER FIBROBLASTS
#84ISOLATION AND PURIFICATION OF EXOSOMES FOR REGENERATIVE MEDICINE
#85FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
#86UNIT FOR ANGIOGENESIS PROMOTION AND/OR NERVE REGENERATION
#87REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF
#88Exosome-based skincare product
#89ANTI-INFLAMMAATORY AND ANTI-VIRAL COMPOSITION BASED ON PLACENTA-DERIVED EXTRACELLULAR VESICLE
#90MESENCHYMAL STROMAL CELLS AND EXTRACELLULAR VESICLES FOR TREATING VIRAL INFECTIONS, INFLAMMATION, AND TISSUE FIBROSIS
#91STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#92TREATMENT OF PREMATURE BIRTH COMPLICATIONS
#93TELOMERE LENGTH MODULATION USING FIBROBLASTS
#94UMBILICAL CORD MESENCHYMAL STEM CELLS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION
#95ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73
#96HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#97INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF
#98MEDICAMENT COMPRISING A COMBINATION OF AMNIOTIC MEMBRANE AND UMBILICAL CORD BLOOD SERUM FOR WOUND HEALING
#99PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE
#100System and method for therapeutic compositions from a plurality of different birth tissues and exosomes
#101METHODS FOR IMPROVING MYELOID BRIDGING IN CORD BLOOD TRANSPLANT RECIPIENTS
#102MATERIALS AND METHODS FOR GENERATING THERAPEUTIC MESENCHYMAL STEM CELLS
#103TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS
#104COMPOSITIONS, KITS AND METHODS FOR STORAGE OF BLOOD PRODUCTS AND METHODS OF USE THEREOF
#105HUMAN UMBILICAL CORD COMPOSITIONS AND METHODS FOR INTRA-ARTICULAR THERAPY
#106TREATMENT OF CARDIOVASCULAR DISEASES
#107Amelioration and Treatment of Opioid Addiction
#108COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF
#109CELL PREPARATION FOR EXTEMPORANEOUS USE, USEFUL FOR HEALING AND REJUVENATION IN VIVO
#110MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES
#111DIAGNOSTIC AND THERAPEUTIC USES OF COMPOSITIONS COMPRISING PURIFIED, ENRICHED POTENT EXOSOMES CONTAINING DISEASE-BASED AND THERAPY BASED SIGNATURE CARGO
#112MESENCHYMAL STEM CELLS WITH ENHANCED THERAPEUTIC PROPERTIES
#113THERAPEUTIC MONOCYTES FOR PREVENTION OF SUICIDAL IDEATION
#114HUMAN UMBILICAL CORD-DERIVED COMPOSITIONS AND USES THEREOF FOR TREATING NEUROPATHY
#115PERIVASCULAR LYSATES AND USES THEREOF
#116STEM CELL LINE FOR TREATMENT OF VARIOUS MEDICAL CONDITIONS
#117METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#118METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#119METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#120FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#121COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER
#122SYSTEMS, METHODS, AND DEVICES FOR ARTIFICIAL PLACENTAS AND AMNIOTIC BED INCUBATORS
#123COMPOSITIONS AND METHODS FOR IMPROVING TREATMENT OUTCOMES FOR PATIENTS HAVING HEMATOLOGICAL MALIGNANCIES USING AN EXPANDED STEM CELL PRODUCT
#124Platelet lysate, and method of preparation thereof
#125COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS
#126HIGH CONCENTRATION CELL PACKAGING AND SHIPPING
#127METHODS FOR ENRICHING POPULATIONS OF CELLS
#128Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
#129Composition and Use of Interleukin Stimulated Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Rheumatoid Arthritis
#130BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF
#131MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#132ENHANCED STEM CELL COMPOSITION
#133MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#134Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue
#135Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention
#136COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY MACROPHAGE-MEDIATED AUTOIMMUNE DISEASE COMPRISING EXOSOMES DERIVED FROM STEM CELLS THAT ARE SURFACE-MODIFIED TO TARGET ACTIVATED MACROPHAGES
#137METHOD OF TREATING CORNEAL PATHOLOGIES WITH OPHTHALMIC COMPOSITION OF UMBILICAL CORD BLOOD PLASMA
#138Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#139USE OF ENDOTHELIAL PROGENITOR CELLS IN REJUVENATING THE MICROVASCULATURE, PREVENTING AGING AND TREATING AGE-RELATED DISEASES
#140UMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE
#141METHODS FOR THE EXPANSION OF MESENCHYMAL STROMAL CELLS
#142METHODS OF CELLULAR REPROGRAMMING
#143USE OF MESENCHYMAL STEM CELL SHEETS FOR PREVENTING UTERINE SCAR FORMATION
#144COMPOSITIONS COMPRISING SMALL EXTRACELLULAR VESICLES DERIVED FROM UMBILICAL CORD BLOOD MONONUCLEAR CELLS WITH ANTI-INFLAMMATORY AND IMMUNOMODULATORY PROPERTIES AND PROCESS FOR OBTAINING THEM
#145FETAL TISSUE EXTRACT, METHODS FOR PRODUCING THE EXTRACT, AND THE USE THEREOF
#146TISSUE HEALING AGENT
#147Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo
#148MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#149USE OF MESENCHYMAL STROMAL CELL EXOSOMES IN ANTENATAL THERAPY
#150HUMAN UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL TRANSFUSION IMMUNOTHERAPY FOR TREATMENT OF CYTOKINE STORM ASSOCIATED WITH CORONAVIRUS INFECTION
#151METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS
#152MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#153Mitochondrial augmentation therapy of muscle diseases
#154COMPOSITIONS OF MORSELIZED UMBILICAL CORD AND/OR AMNIOTIC MEMBRANE AND METHODS OF USE THEREOF
#155Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#156MITOCHONDRIAL AUGMENTATION THERAPY OF BRAIN DISEASES
#157Mitochondrial augmentation therapy of ocular diseases
#158NEONATAL STROMAL CELLS HAVING LOW MHC-I EXPRESSION AND USES THEROF
#159Method of reinforcing efficacy of stem cells using ethionamide
#160Genetically modified non-human animal with human or chimeric CD3e
#161Methods for the treatment of autism spectrum disorders
#162TISSUE HEALING AGENT
#163ISOLATION OF EXTRACELLULAR VESICLES BY PRECIPITATION OR IMMOBILIZATION USING POLYETHYLENIMINE AND POLYETHYLENIMINE-COATED SOLID SUPPORTS
#164Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
#165MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
#166Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease
#167COMPOSTION FOR USE IN IMMUNOTHERAPY
#168Methods and systems for activating cells to treat aging
#169MITOCHONDRIAL AUGMENTATION THERAPY OF RENAL DISEASES
#170Minimal volume reprogramming of mononuclear cells
#171Transplant material for treatment of heart disease
#172Placental Tissue Particulate Compositions and Methods of Use
#173Methods for protecting a parathyroid
#174METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#175CELLULAR, ORGAN, AND WHOLE-BODY REJUVENATION UTILIZING CORD BLOOD PLASMA AND PTEROSTILBENE
#176AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
#177COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME
#178Placental tissue component compositions for treatment of skin defects and methods using same
#179COMPOSITION AND METHOD FOR TREATING SKIN CONDITION
#180MESENCHYMAL STEM CELLS OR STROMAL CELLS HARBORING MODIFIED RNAS ENCODING VEGF AND BMP POLYPEPTIDES
#181FOETAL POLYMIX OF MESENCHYMAL STEM CELLS UNDER HYPOXIC CONDITIONS FOR THE TREATMENT OF CLINICAL DISORDERS AND DISEASES
#182MESENCHYMAL STEM CELL THERAPY OF LEIGH SYNDROME
#183Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#184METHOD FOR ISOLATING STEM CELLS FROM HUMAN UMBILICAL CORD
#185PRODUCTION AND USE OF EXTRACELLULAR VESICLES
#186Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#187Materials and methods for generating therapeutic mesenchymal stem cells
#188Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
#189Umbilical tissue compositions and methods of use
#190ISOLATION, CULTIVATION AND USES OF STEM/PROGENITOR CELLS
#191Methods for nuclear reprogramming using synthetic transcription factors
#192Umbilical cord mesenchymal stem cells (MSCs) and culture method and application thereof
#193Umbilical Cord Artery Perivascular Stem Cell Injection Solution for Treating Ischemic Diseases and Preparation Method Thereof
#194Compositions containing amniotic components and methods for preparation and use thereof
#195METHOD OF ISOLATION OF STEM CELLS FROM HYPERTHERMIA CONDITIONED TISSUES AND USING THE SAME
#196Method for improving stem cell migration using ethionamide
#197NATIVE WHARTON'S JELLY STEM CELLS AND THEIR PURIFICATION
#198NATURAL KILLER CELLS AND USES THEREOF
#199METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS
#200METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#201METHOD FOR OBTAINING A COMPOSITION CONTAINING A SPECIFIC POPULATION OF UMBILICAL CORD MESENCHYMAL CELLS AND USES THEREOF
#202USE OF UMBILICAL CORD BLOOD DERIVED EXOSOMES FOR TISSUE REPAIR
#203PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS
#204STEM CELL PREPARATIONS AND APPLICATION IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF OSTEOARTHRITIS
#205Methods and compositions relating to exosomes
#206STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#207STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS
#208Methods for protecting a parathyroid
#209Non-covalently assembled conductive hydrogel
#210Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#211Selection and use of umbilical cord cell fractions suitable for transplantation
#212Use of Post-Transplant Cyclophosphamide Treated Allogenic Marrow Infiltrating Lymphocytes to Augment Anti-Tumor Immunity
#213UMBILICAL CORD BLOOD SERUM AND UMBILICAL CORD BLOOD PLASMA PREPARATION IN COMBINATION WITH A NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND FREEZE-DRYING THE COMPOSITION
#214METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS
#215Selection and use of umbilical cord cell fractions suitable for transplantation
#216Composition derived from mammalian umbilical cord and Whartons jelly for use in therapeutic and regenerative applications
#217Use of composition comprising exosome derived from adipose-derived stem cell as effective ingredient in ameliorating dermatitis
#218Systems and Methods for Delivering Exosomes Through the Blood-Brain Barrier
#219TISSUE HEALING AGENT
#220Methods for the treatment of autism spectrum disorders
#221Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders
#222Methods of treating systemic graft-versus-host disease with extracellular vesicles
#223Compositions and methods for treating a clinical condition through the use of hematopoietic stem cells
#224Compositions and methods for the treatment of demyelinating conditions
#225Cell population comprising adherent cells derived from fetal appendage, method for producing the same, and pharmaceutical composition
#226COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION
#227Systems, methods, and devices for artificial placentas and amniotic bed incubators
#228CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#229Methods of Treating Cerebral Palsy Using High Dose Allogeneic Umbilical Cord Blood
#230COMPOSITION FOR USE IN IMMUNOTHERAPY
#231Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using Them
#232Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis
#233Methods and systems for generation, use, and delivery of activated stem cells
#234Composition for treating neonatal HIE
#235Genetically modified non-human animal with human or chimeric CD3e
#236COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF
#237Composition comprising a substantially pure population of multipotent stromal cells encapsulated in platelet-poor plasma (PPP)
#238Methods of Treating Brain Injury Using Cord Blood or a Component Thereof
#239Placental tissue component compositions for treatment of skin defects and methods using same
#240Compositions for treatment of arthritis
#241Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
#242PCNT as a target protein for treatment or diagnosis of brain-nervous system diseases
#243TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION
#244ENHANCED HETATOPOIETIC STEM CELL TRANSPLANTATION
#245TREATMENT OF PREMATURE BIRTH COMPLICATIONS
#246Mammalian birth tissue composition for tumor treatment
#247MICRONIZED WHARTON'S JELLY
#248Compositions containing amniotic components and methods for preparation and use thereof
#249COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING
#250COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING
#251Isolation, cultivation and uses of stem/progenitor cells
#252Preparation of artificial tissues by means of tissue engineering using fibrin and agarose biomaterials
#253Sperm activator and uses thereof
#254Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#255AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS
#256Systems, methods, and devices for artificial placentas and amniotic bed incubators
#257Postpartum cells derived from placental tissue, and methods of making and using the same
#258Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
#259Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#260GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR WOUND HEALING
#261METHOD OF INHIBITING ANGIOGENESIS
#262Human tissue derived compositions and uses thereof
#263Stem Cell-Derived Exosomes Containing a High Amount of Growth Factors
#264STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS
#265ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC)
#266Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
#267Composition Including GDF11 and Use Thereof
#268Enhanced stem cell composition
#269TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
#270Selection of human hematopoetic stem cells using EPCR
#271hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
#272Vascularized biphasic tissue constructs
#273Composition for inducing beige adipocyte differentiation containing exosome derived from stem cells
#274In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells
#275Fetal support tissue products and methods of use
#276Materials and methods for controlling vasculogenesis from endothelial colony forming cells
#277Minimal volume reprogramming of mononuclear cells
#278Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#279Uses of expanded populations of hematopoietic stem/progenitor cells
#280METHODS OF OBTAINING CELLS FROM HUMAN POSTPARTUM UMBILICAL CORD ARTERIAL TISSUE
#281METHOD OF MODULATING MÜLLER GLIA CELLS
#282Composition for preventing or treating inflammatory diseases, containing, as active ingredient, stem cells overexpressing SOD3
#283Soft tissue repair and regeneration using postpartum-derived cells and cell products
#284TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
#285Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#286MAPC treatment of brain injuries and diseases
#287CORD BLOOD THERAPY TO TREAT CHRONIC DISEASE CAUSED BY L-FORM BACTERIA
#288Use of umbilical mesenchymal stem cells for treating pulmonary fibrosis
#289Lithium stimulation of cord blood stem cell proliferation and growth factor production
#290Umbilical cord-derived adherent stem cells, preparation method therefor, and use thereof
#291DEVICES AND METHODS FOR SELECTING APOPTOSIS-SIGNALING RESISTANT CELLS, AND USES THEREOF
#292Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion
#293FLOWABLE TISSUE COMPOSITIONS WITH ENHANCED BUOYANCY PROPERTIES CONTAINING ANTIBIOTICS AND DERIVATIVES THEREOF
#294MAPC treatment of brain injuries and diseases
#295Injectable and stable hydrogels with dynamic properties modulated by biocompatible catalysts
#296Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#297COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING
#298Compositions and methods for prolonged cell storage
#299Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
#300Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans